Evidence map›Paper›PMID 37984182›Full record

ArticleSocial science & medicine (1982)2023

Identifying longitudinal patterns of HIV treatment (dis)engagement and re-engagement from oral histories of virologically unsuppressed persons in Uganda: A thematic trajectory analysis.

Joseph G Rosen, Neema Nakyanjo, William G Ddaaki, Tongying Zhao, Anh Van Vo, Rosette Nakubulwa, Charles Ssekyewa, Dauda Isabirye, Ruth L Katono, Proscovia Nabakka and 9 more

Open access · greenAbstract read
In one paragraph

Article in Social science & medicine (1982), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 2 countries.

Joseph G RosenDepartment of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. Electronic address: jrosen72@jhu.edu.
Neema NakyanjoRakai Health Sciences Program, Entebbe, Uganda.
William G DdaakiRakai Health Sciences Program, Entebbe, Uganda.
Tongying ZhaoDepartment of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Anh Van VoDepartment of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Rosette NakubulwaRakai Health Sciences Program, Entebbe, Uganda.
Charles SsekyewaRakai Health Sciences Program, Entebbe, Uganda.
Dauda IsabiryeRakai Health Sciences Program, Entebbe, Uganda.
Ruth L KatonoRakai Health Sciences Program, Entebbe, Uganda.
Proscovia NabakkaRakai Health Sciences Program, Entebbe, Uganda.
Richard J SsemwangaRakai Health Sciences Program, Entebbe, Uganda.
Grace KigoziRakai Health Sciences Program, Entebbe, Uganda.
Silas OdiyaRakai Health Sciences Program, Entebbe, Uganda.
Gertrude NakigoziRakai Health Sciences Program, Entebbe, Uganda.
Fred NalugodaRakai Health Sciences Program, Entebbe, Uganda.
Godfrey KigoziRakai Health Sciences Program, Entebbe, Uganda.
Joseph KagaayiRakai Health Sciences Program, Entebbe, Uganda.
M Kate GrabowskiRakai Health Sciences Program, Entebbe, Uganda; Division of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Caitlin E KennedyDepartment of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA; Rakai Health Sciences Program, Entebbe, Uganda.
Rakai Health Sciences Program · UGJohns Hopkins University · US

Funding

The Brown Initiative in HIV and AIDS Clinical Research for Minority CommunitiesR25MH083620 · NIMH · MIRIAM HOSPITAL · PI NUNN, AMY STEWART · 2008 to 2025
$3.7M
Long-term impact of universal treatment and dolutegravir on population HIV virologic and incidence outcomes in Africa: The LONGVIEW StudyR01AI155080 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRABOWSKI, MARY KATHRYN · 2021 to 2024
$2.5M
ART diversion in Rakai, UgandaR21AI145682 · NIAID · JOHNS HOPKINS UNIVERSITY · PI KENNEDY, CAITLIN E, NALUGODA, FRED · 2020 to 2021
$415k
Viral Load Trajectories and Dynamics among People Living with HIV in Rakai, Uganda: A Mixed-Methods StudyF31MH126796 · NIMH · JOHNS HOPKINS UNIVERSITY · PI ROSEN, JOSEPH GREGORY · 2021 to 2022
$79k
NIAID NIH HHS R01 AI155080NIAID NIH HHS R21 AI145682NIMH NIH HHS F31 MH126796NIMH NIH HHS R25 MH083620
6 · The paper itself

Abstract

backgroundThere is limited study of persons deemed "harder to reach" by HIV treatment services, including those discontinuing or never initiating antiretroviral therapy (ART). We conducted narrative research in southern Uganda with virologically unsuppressed persons identified through population-based sampling to discern longitudinal patterns in HIV service engagement and identify factors shaping treatment persistence.

methodsIn mid-2022, we sampled adult participants with high-level HIV viremia (≥1000 RNA copies/mL) from the prospective, population-based Rakai Community Cohort Study. Using life history calendars, we conducted initial and follow-up in-depth interviews to elicit oral histories of participants' journeys in HIV care, from diagnosis to the present. We then used thematic trajectory analysis to identify discrete archetypes of HIV treatment engagement by "re-storying" participant narratives and visualizing HIV treatment timelines derived from interviews and abstracted clinical data.

resultsThirty-eight participants (median age: 34 years, 68% men) completed 75 interviews. We identified six HIV care engagement archetypes from narrative timelines: (1) delayed ART initiation, (2) early treatment discontinuation, (3) treatment cycling, (4) prolonged treatment interruption, (5) transfer-related care disruption, and (6) episodic viremia. Patterns of service (dis)engagement were highly gendered, occurred in the presence and absence of optimal ART adherence, and were shaped by various factors emerging at different time points, including: denial of HIV serostatus and disclosure concerns; worsening HIV-related symptoms; psychological distress and depression; social support; intimate partner violence; ART side effects; accessibility constraints during periods of mobility; incarceration; and inflexible ART dispensing regulations.

conclusionsIdentified trajectories uncovered heterogeneities in both the timing and drivers of ART (re-)initiation and (dis)continuity, demonstrating the distinct characteristics and needs of people with different patterns of HIV treatment engagement throughout the life course. Enhanced mental health service provision, expanded eligibility for differentiated service delivery models, and streamlined facility switching processes may facilitate timely (re-)engagement in HIV services.

Indexed as

Anti-HIV AgentsHIV InfectionsAdultCohort StudiesFemaleHumansMaleProspective StudiesUgandaViremiaAnti-HIV AgentsAntiretroviral therapyHIV care retentionNarrative analysisQualitative researchSub-Saharan AfricaUniversal test and treatViral load suppression

Identifiers

PMID37984182
PMCPMC10841599
OpenAlexW4388662557

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.